James J. Burns & Company LLC Sells 4,286 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

James J. Burns & Company LLC trimmed its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 29.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,429 shares of the company's stock after selling 4,286 shares during the quarter. James J. Burns & Company LLC's holdings in Henry Schein were worth $714,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Investment Management Corp VA ADV bought a new stake in shares of Henry Schein during the fourth quarter worth $32,000. Venturi Wealth Management LLC grew its holdings in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after purchasing an additional 569 shares during the last quarter. Quent Capital LLC grew its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the last quarter. Finally, Allworth Financial LP grew its holdings in shares of Henry Schein by 180.7% during the fourth quarter. Allworth Financial LP now owns 946 shares of the company's stock worth $71,000 after purchasing an additional 609 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Trading Down 0.6%

NASDAQ:HSIC traded down $0.43 during mid-day trading on Monday, hitting $69.56. The company had a trading volume of 2,497,178 shares, compared to its average volume of 1,675,429. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The business's fifty day moving average is $67.65 and its two-hundred day moving average is $71.69. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market cap of $8.47 billion, a P/E ratio of 28.63, a P/E/G ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the prior year, the firm posted $1.10 earnings per share. The company's quarterly revenue was down .1% on a year-over-year basis. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Barrington Research cut their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Piper Sandler cut their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Finally, Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, Henry Schein currently has an average rating of "Moderate Buy" and a consensus target price of $79.30.

Insiders Place Their Bets

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.